Roivant Sciences Ltd
ROIV
$10.99+0.02 (+0.18%)
Jul 5, 2025, 4:00 PM
Financials
| 52Week High | 13.06 | 52Week Low | 8.73 |
| Beta | 1.15 | Current Ratio Annual | 33.47 |
| Current Ratio Quarterly | 33.47 | Gross Margin TTM | 36.93 |
| Market Cap | 7.47B | Net Profit Margin TTM | -225.71 |
| Operating Margin TTM | -1,312.67 | Price To Book | 1.59 |
| Price To Sales TTM | 98.05 | Quick Ratio Annual | 33.47 |
| Quick Ratio Quarterly | 33.47 | Return On Assets TTM | -2.87 |
| Return On Equity TTM | -3.36 | Return On Investment TTM | -3.31 |
| Revenue Growth3Y | -19.30 | Revenue Growth5Y | -15.56 |
| Revenue Growth Quarterly Yoy | -73.83 | Revenue Growth TTMYoy | -38.94 |
| Revenue Per Share TTM | 0.11 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 310 | 55 | 53 | 89 | 106 | 55 | 557.59M | $5.55B |
| Jun 30, 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $0 |
| Change | 310(100%) | 55(100%) | 53(100%) | 89(100%) | 106(100%) | 55(100%) | 557.59M(100%) | $5.55B(100%) |